FindTrial
Sign In

Prognostic analysis of patients with diffuse gliomas coexisting with tumors

Prognostic analysis of patients with diffuse gliomas coexisting with tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085839
Enrollment
Unknown
Registered
2024-06-19
Start date
2024-06-22
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Glioma:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) age above 18 years old; 2) Diagnosed with glioma; 3) including patients with intracranial/other site tumors; 4) Key clinical and survival data (including age, sex, surgical intervention, survival time, and outcome) can be obtained from the SEER database.

Exclusion criteria

Exclusion criteria: 1) Exclude children; 2) Exclude patients who lack the above key clinical data.

Design outcomes

Primary

MeasureTime frame
Overall survival;Cancer specific survival (CSS);—

Countries

China

Contacts

Public ContactXiaodong Niu

West China Hospital of Sichuan University

allen_niuxd10@163.com+86 177 3683 1691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026